FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.

Mounjaro (tirzepatide) is a prescription drug used ... Whether you have health insurance or not, cost may be a factor when you’re considering Mounjaro. What you’ll pay for Mounjaro may depend ...

leading to inequality of access and patient outcomes services that already exist would need to be decommissioned to provide the resources required to deliver tirzepatide. Budget impact: The ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

Weight loss efficacy: While both medications are highly effective for weight loss, studies suggest tirzepatide may lead to greater reductions in body weight due to its dual-action mechanism. Cost ...